LABD vs. LABU
Compare and contrast key facts about Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily S&P Biotech Bull 3x Shares (LABU).
LABD and LABU are both exchange-traded funds (ETFs), meaning they are traded on stock exchanges and can be bought and sold throughout the day. LABD is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (-300%). It was launched on May 28, 2015. LABU is a passively managed fund by Direxion that tracks the performance of the S&P Biotechnology Select Industry Index (300%). It was launched on May 28, 2015. Both LABD and LABU are passive ETFs, meaning that they are not actively managed but aim to replicate the performance of the underlying index as closely as possible.
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: LABD or LABU.
Performance
LABD vs. LABU - Performance Comparison
Returns By Period
In the year-to-date period, LABD achieves a -30.28% return, which is significantly lower than LABU's -12.24% return.
LABD
-30.28%
10.46%
-20.72%
-64.06%
-53.44%
N/A
LABU
-12.24%
-14.44%
2.30%
55.02%
-35.08%
N/A
Key characteristics
| LABD | LABU | |
|---|---|---|
| Sharpe Ratio | -0.82 | 0.75 |
| Sortino Ratio | -1.26 | 1.45 |
| Omega Ratio | 0.86 | 1.17 |
| Calmar Ratio | -0.65 | 0.60 |
| Martin Ratio | -1.11 | 2.18 |
| Ulcer Index | 58.70% | 27.09% |
| Daily Std Dev | 79.24% | 79.14% |
| Max Drawdown | -99.97% | -98.92% |
| Current Drawdown | -99.96% | -97.67% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
LABD vs. LABU - Expense Ratio Comparison
LABD has a 1.06% expense ratio, which is lower than LABU's 1.12% expense ratio.
Correlation
The correlation between LABD and LABU is -1.00. This indicates that the assets' prices tend to move in opposite directions. Negative correlation can be particularly beneficial for diversification and risk management, as one asset may offset the losses of the other during market fluctuations.
Risk-Adjusted Performance
LABD vs. LABU - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Direxion Daily S&P Biotech Bear 3x Shares (LABD) and Direxion Daily S&P Biotech Bull 3x Shares (LABU). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
LABD vs. LABU - Dividend Comparison
LABD's dividend yield for the trailing twelve months is around 4.55%, more than LABU's 0.49% yield.
| TTM | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|
LABD Direxion Daily S&P Biotech Bear 3x Shares | 4.55% | 6.14% | 0.53% | 0.00% | 3.96% | 1.75% | 0.80% | 0.00% |
LABU Direxion Daily S&P Biotech Bull 3x Shares | 0.49% | 0.35% | 0.00% | 0.00% | 0.00% | 0.28% | 0.64% | 0.17% |
Drawdowns
LABD vs. LABU - Drawdown Comparison
The maximum LABD drawdown since its inception was -99.97%, roughly equal to the maximum LABU drawdown of -98.92%. Use the drawdown chart below to compare losses from any high point for LABD and LABU. For additional features, visit the drawdowns tool.
Volatility
LABD vs. LABU - Volatility Comparison
The current volatility for Direxion Daily S&P Biotech Bear 3x Shares (LABD) is 23.72%, while Direxion Daily S&P Biotech Bull 3x Shares (LABU) has a volatility of 25.61%. This indicates that LABD experiences smaller price fluctuations and is considered to be less risky than LABU based on this measure. The chart below showcases a comparison of their rolling one-month volatility.